These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 6374433)

  • 21. [Comparative multicenter study of bovine insulin with forms more purified of swine and human insulin in the treatment of type 1 diabetes mellitus].
    Russo EM; Wajchenberg BL; Romaldini JH; Liberman B; Gross JL; Reis LC
    AMB Rev Assoc Med Bras; 1991; 37(2):73-8. PubMed ID: 1658875
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical experiences with the substitution of biosynthetic human insulin in children and adolescents with type I diabetes].
    Hürter P; von Schütz W; Zick R; Stolzenbach K
    Monatsschr Kinderheilkd; 1985 May; 133(5):277-83. PubMed ID: 3892270
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of the activity profiles of two fixed combinations of regular/NPH human insulin (recombinant DNA) of different compositions with a fixed regular/NPH porcine insulin combination (PPI) in insulin-dependent diabetic individuals.
    Sailer D; Ludwig T; Kolb S
    Diabetes Care; 1982; 5 Suppl 2():57-9. PubMed ID: 6765542
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Insulin-dependent diabetes: clinical aspects and therapy].
    Heinze E
    Monatsschr Kinderheilkd; 1984 Oct; 132(10):803-6. PubMed ID: 6392862
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Transitory diabetes mellitus in the newborn infant].
    Steigenberger H
    Monatsschr Kinderheilkd; 1986 Apr; 134(4):207-8. PubMed ID: 3517626
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The insulins.
    Montgomery DA
    Practitioner; 1979 Mar; 222(1329):349-56. PubMed ID: 109827
    [No Abstract]   [Full Text] [Related]  

  • 27. Biosynthetic human insulin in the treatment of diabetes. A double-blind crossover trial in established diabetic patients.
    Clark AJ; Adeniyi-Jones RO; Knight G; Leiper JM; Wiles PG; Jones RH; Keen H; MacCuish AC; Ward JD; Watkins PJ; Cauldwell JM; Glynne A; Scotton JB
    Lancet; 1982 Aug; 2(8294):354-7. PubMed ID: 6124760
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of the biologic activity of biosynthetic human insulin and natural pork insulin in juvenile-onset diabetic subjects assessed by the glucose controlled insulin infusion system.
    Klier M; Kerner W; Torres AA; Pfeiffer EF
    Diabetes Care; 1981; 4(2):193-5. PubMed ID: 7011725
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The plasma glucose response of normal fasting subjects to neutral regular and NPH biosynthetic human and purified pork insulins.
    Galloway JA; Spradlin CT; Root MA; Fineberg SE
    Diabetes Care; 1981; 4(2):183-8. PubMed ID: 7011723
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mixed insulins and insulin regimens.
    Boyd DW
    Diabet Med; 1984 Sep; 1(3):243. PubMed ID: 6242810
    [No Abstract]   [Full Text] [Related]  

  • 31. Human insulins: an update.
    Drug Ther Bull; 1989 Mar; 27(6):21-4. PubMed ID: 2519141
    [No Abstract]   [Full Text] [Related]  

  • 32. Comparison of the biologic activity of porcine and semisynthetic human insulins using the glucose-controlled insulin infusion system in insulin-dependent diabetes.
    Szekeres A; Worcester B; Ascher MS; Tuxen D; Heyendal R; Walsh KM; Charles MA
    Diabetes Care; 1983; 6(2):193-6. PubMed ID: 6343025
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human insulin (recombinant DNA) in the treatment of patients with newly diagnosed insulin-dependent diabetes mellitus (IDDM).
    Lotz N; Bachmann W; Mehnert H
    Diabetes Care; 1982; 5 Suppl 2():149-51. PubMed ID: 6765527
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transferring patients with insulin-dependent diabetes mellitus from animal-source insulins to recombinant DNA human insulin: clinical experience.
    Davidson JK
    Clin Ther; 1989; 11(3):319-30. PubMed ID: 2663162
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The therapeutic efficacy of human insulin (recombinant DNA) in patients with insulin-dependent diabetes mellitus: a comparative study with purified porcine insulin.
    Howey DC; Fineberg SE; Nolen PA; Stone MI; Gibson RG; Fineberg NS; Galloway JA
    Diabetes Care; 1982; 5 Suppl 2():73-7. PubMed ID: 6765546
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treat human diabetes with human insulin.
    Shelmet JJ
    N J Med; 1987 Oct; 84(10):723-4. PubMed ID: 3317140
    [No Abstract]   [Full Text] [Related]  

  • 37. [Guide for the young diabetic. 5th lesson. Human insulin and therapeutic insulins].
    Geussens H; Dorchy H; Ernould C; François B; Hens G; Loeb H
    Rev Med Liege; 1972 Aug; 27(15):511-3. PubMed ID: 4676307
    [No Abstract]   [Full Text] [Related]  

  • 38. Regular insulin.
    Gaines C
    Crit Care Nurse; 1990 Apr; 10(4):12-7. PubMed ID: 2183971
    [No Abstract]   [Full Text] [Related]  

  • 39. An appraisal of the role of biosynthetic human insulin in the future treatment of diabetes mellitus.
    Gerich JE
    Diabetes Care; 1981; 4(2):262-4. PubMed ID: 7011743
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Remission of diabetes mellitus treated from the beginning with intensive insulin. Comparative effects of porcine and human insulin].
    Fenichel P; Viard R; Harter M; Issa-Sayegh M; Brucker F; Strulo S; Kozlowski JM; Hayoun H
    Presse Med; 1983 Dec; 12(44):2822-3. PubMed ID: 6228857
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.